ENO1 and cancer: More in-depth studies are needed to fully dissect the signalling pathways and the molecular mechanism(s) leading to the cell surface exposure of alpha-enolase and to clarify the existence of specific membrane subdomains, where enolase and its interactors may contribute to multiple functions in addition to plasminogen binding, both in non-tumourigenic and cancer cells.